Activity record

PGDB_A005707

Assay: biochemicalTarget: CRBNQC: standardized
Activity overview

inhibition = 70-80 %

TargetCRBN
E3 ligaseCRBN
Concentration2 uM
Assay / ReadoutHTRF / % Inhibition
Assay IDPGDB_AS001031
PatentWO2026061475A1
QC statusstandardized
Evidence details

Compound, assay context, and source

Compound

2D structure for PGDB_C030396
Compound IDPGDB_C030396
CompoundGT-10613
Source record IDPGDB_C030396
InChIKeyVORLELDORBTBTC-UHFFFAOYSA-N

Assay context

Assay IDPGDB_AS001031
Assay familybiochemical
Assay systemcell_based
Readout% Inhibition
TechnologyHTRF
Concentration2 uM
Detection targetcell_inhibition
TargetCRBN
E3CRBN
OrganismHomo sapiens

Source evidence

Patent IDWO2026061475A1
Compound location

GT-10613

GT-10613 enlarged structureGT-10613 location on patent page 77
Activity table
Page 215 · table start
Page 216 · table end